CHICAGO–(BUSINESS WIRE)–The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading … [Read more…]
FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / … [Read more…]
CompHealth, Weatherby Healthcare, and Global Medical Staffing earn top satisfaction scores, demonstrating CHG Healthcare’s industry‑leading commitment to provider experience and service excellence. MIDVALE, Utah–(BUSINESS WIRE)–CHG Healthcare, the nation’s largest physician staffing firm and industry leader in healthcare workforce success, announced today that three of its staffing brands — CompHealth, Weatherby Healthcare, and Global Medical Staffing … [Read more…]
Expert-led live sessions to run during Eating Disorders Awareness Week ST. PAUL, Minn.–(BUSINESS WIRE)–The Emily Program, a national leader in eating disorder specialty care and behavioral health services, today announced its 2026 Learn with Emily webinar series. Designed for advocates, caregivers, and clinicians, the free, expert-led series explores insights on eating disorder care and recovery. … [Read more…]
BOSTON–(BUSINESS WIRE)–#activitiesofdailyliving—Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1™. This clearance is supported by data from two clinical studies: a randomized, sham-controlled trial and a 90-day home-use study. Together, these studies demonstrated consistent improvements in tremor severity … [Read more…]
Establishes New Benchmark for High Identity Assurance Based on Accredited Testing of Industry Standard LONDON–(BUSINESS WIRE)–iProov, the world’s leading provider of science-based biometric identity verification solutions, today announced that its Dynamic Liveness technology is the first and only solution to successfully achieve an Ingenium Level 4 evaluation and the CEN/TS 18099 High technical specification for … [Read more…]
Galderma unveils We Are All Sculptra, a global campaign capturing the clinical performance of Sculptra® across nine diverse patient profiles and journeys, over two years1 Backed by over 25 years of clinical use, Sculptra continues to prove its versatility as a regenerative treatment that works across all three layers of the skin2-6 The campaign captures … [Read more…]
Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 SANTA CLARA, Calif.–(BUSINESS WIRE)–$A #BringGreatScienceToLife—Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code SK006, as the only FDA-approved companion diagnostic indicated to aid in identifying patients with epithelial ovarian, fallopian … [Read more…]
Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer Phase 3 PANOVA-3 trial showed a statistically significant improvement in overall survival (OS) and significantly extended time to pain progression in patients treated with Optune Pax Optune Pax is a wearable … [Read more…]
DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company’s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and … [Read more…]
